openPR Logo
Press release

(2021-2030) Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

The Business Research Company offers "Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2021: COVID-19 Impact And Recovery To 2030" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The benign prostatic hyperplasia (bph) treatment devices and equipment market report describes and explains the global benign prostatic hyperplasia (bph) treatment devices and equipment market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

Place A Direct Purchase Order Of The Report Here
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2431

The benign prostatic hyperplasia (BPH) treatment devices and equipment market consists of sales of benign prostatic hyperplasia treatment devices and equipment and related services. Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of an enlarged prostate gland which causes blockade of urethra, the tube that carries urine from the bladder. The market is segmented into resectoscopes, radiofrequency ablation device, urology lasers, prostatic stents and implants.

The global benign prostatic hyperplasia (BPH) treatment devices and equipment market is expected to decline from $2.1 billion in 2020 to $2.04 billion in 2021 at a compound annual growth rate (CAGR) of -2.9%. The decline is mainly due to deferment of treatments due to the outbreak of COVID-19 that has led to fall in demand for the equipment. The BPH treatment devices and equipment market is expected to reach $2.73 billion in 2025 at a CAGR of 7.6%.

Request For The Sample Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

Some of the major players of the benign prostatic hyperplasia (bph) treatment devices and equipment market are Karl Storz, Lumenis, Olympus, Urologix, and Boston scientific Inc.
The countries covered in the global benign prostatic hyperplasia (bph) treatment devices and equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global benign prostatic hyperplasia (bph) treatment devices and equipment market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global benign prostatic hyperplasia (bph) treatment devices and equipment market is segmented -
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home
3) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery Others

Read More On The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Few Points From Table Of Content
1. Executive Summary
2. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Characteristics
3. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Trends And Strategies
4. Impact Of COVID-19 On Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment
5. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Size And Growth
....
26. Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
27. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
29. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/

Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model (www.globalmarketmodel.com) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release (2021-2030) Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends here

News-ID: 2315053 • Views:

More Releases from The Business research company

Competitive Landscape: Key Market Leaders and Rising Competitors in the Contraceptives Market
Competitive Landscape: Key Market Leaders and Rising Competitors in the Contrace …
The contraceptives market is positioned for significant expansion over the coming years, driven by innovation and growing awareness about reproductive health. Advances in technology, evolving consumer preferences, and broader access to contraceptive options are shaping this dynamic industry. Below is a detailed overview of the market size, key players, prevailing trends, and segmentation. Forecasted Growth and Market Size of the Contraceptives Market by 2030 The contraceptives market is projected to
Growth Patterns, Market Segmentation, and Competitive Approaches Influencing the Constrained Peptide Drugs Market
Growth Patterns, Market Segmentation, and Competitive Approaches Influencing the …
The constrained peptide drugs market is attracting significant attention due to its promising growth potential and innovative therapeutic applications. As the pharmaceutical industry advances, these specialized peptides are expected to revolutionize treatment options for complex diseases, offering improved efficacy and targeted delivery. Here's a detailed exploration of the market's size, key players, emerging trends, and major segments shaping its future. Projected Market Value and Growth Rates for Constrained Peptide Drugs
Segmentation, Major Trends, and Competitive Overview of the Conjugated Monoclonal Antibodies Market
Segmentation, Major Trends, and Competitive Overview of the Conjugated Monoclona …
The conjugated monoclonal antibodies market is on track for significant expansion over the coming years, driven by advancements in technology and increased adoption in cancer treatment. This segment holds promising potential as it evolves with new innovations and growing investment in oncology research. Let's explore the current market valuation, key players, emerging trends, and the main segments shaping the future of conjugated monoclonal antibodies. Projected Market Valuation and Growth Path of
Leading Companies Reinforcing Their Presence in the Compression Therapy Market
Leading Companies Reinforcing Their Presence in the Compression Therapy Market
The compression therapy industry is poised for remarkable expansion as healthcare continues to evolve with new technologies and growing patient needs. This sector is becoming increasingly vital, especially for managing vascular and circulatory conditions, with innovations driving greater adoption and improved outcomes. Below is a detailed look at the market's size, key players, influential trends, and segmentation. Compression Therapy Market Size Set for Significant Growth by 2030 The compression therapy

All 5 Releases


More Releases for BPH

Benign Prostatic Hyperplasia (BPH) Market to Reach USD 18.4 Billion by 2034
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that affects a significant proportion of aging men, leading to lower urinary tract symptoms (LUTS) such as urinary urgency, weak stream, and nocturia. As life expectancy increases globally, the prevalence of BPH is on the rise, creating sustained demand for effective treatment options ranging from pharmaceuticals to minimally invasive surgeries. Download Full PDF Sample Copy of Market Report @
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.
BPH Surgical Treatment Market worth $17.19 billion in 2030
Browse 368 market data Tables and 59 Figures spread through 328 Pages and in-depth TOC on "BPH Surgical Treatment Market by Type (TURP, Laser, Rezum, Urolift, Ablation, PAE), Drug Type (Alpha Blocker (Alfuzosin), Alpha Reductase Inhibitor (Dutastride), Therapy (Mono, Combination), End Users (Hospitals) - Global Forecast to 2030 The global [https://www.marketsandmarkets.com/Market-Reports/benign-prostatic-hyperplasia-treatment-market-198000374.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=benignprostatichyperplasiasurgicaltreatmentmarket], valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion in
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.
Benign Prostatic Hyperplasia (BPH) Treatment Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Benign Prostatic Hyperplasia (BPH) Treatment Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The benign prostatic hyperplasia (BPH) treatment market is experiencing significant growth due to the rising prevalence of BPH among the aging male
How big is Benign Prostate Hyperplasia (BPH) Market?
Benign Prostate Hyperplasia (BPH) Market is forecasted to reach at a CAGR of 6% during the forecast period (2024-2031). The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Benign Prostate Hyperplasia (BPH) market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market